Luke Seikkula
Chief Operating Officer bei LA JOLLA PHARMACEUTICAL COMPANY
Profil
Luke Seikkula is currently a Senior Vice President-Pharmaceutical Operations at La Jolla Pharmaceutical Co. He previously worked as a Senior Director-Materials & Logistics at Spectrum Pharmaceuticals, Inc. and Allos Therapeutics, Inc. He also worked as a Materials Manager-Ambulatory Infusion Systems at Abbott Laboratories.
Mr. Seikkula holds an MBA degree from San Diego State University and an undergraduate degree from Winona State University.
Aktive Positionen von Luke Seikkula
| Unternehmen | Position | Beginn |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Operating Officer | 01.01.2019 |
Ehemalige bekannte Positionen von Luke Seikkula
| Unternehmen | Position | Ende |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2015 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Corporate Officer/Principal | 01.01.2012 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2001 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Ausbildung von Luke Seikkula
| San Diego State University | Masters Business Admin |
| Winona State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
